India's second-largest lender ICICI Bank today announced 35% drop in net profit at Rs 743.76 crore for the quarter ended March 31, 2009 when compared to Rs 1149.84 crore in the year-ago period.
In addition, the lender's total income also fell to Rs 9203.36 crore from Rs 10390.92 crore in the corresponding period in the previous year.
For the full-year ended March, ICICI Bank's net profit fell 9.40% percent to Rs 3758.13 crore, as compared to Rs 4157.73 crore for the year ended March 31, 2008.
Leading drug maker Cipla on Friday reported 40.94% surge in its net profit for the fourth quarter ended March 31.
The company posted net profit of Rs 252.92 crore, against Rs 179.45 crore in the same quarter ended March 31, 2008.
Further, during the quarter, total operating income of the company rose to Rs 1,366.74 crore, as against Rs 1,122.10 crore in the same quarter of the previous fiscal.
For the full-year ended March, the company posted a net profit of Rs 767 crore, as compared to Rs 701 crore in the corresponding period last year
Navratna defence PSU Bharat Electronics Ltd. (BEL) on Friday informed that its net profit for the January-March 2009 quarter grew by 10.6% to Rs 559.43 crore over the corresponding year-ago period.
The company had posted a net profit of Rs 504.83 crore in the same quarter, previous year.
Further, company's total income also rose to Rs 2783.03 crore in the quarter, up from Rs 2339.16 crore in the previous year-ago quarter.
Exhibiting one of its worst quarterly performances ever, Ranbaxy Laboratories – now owned by Japanese firm Daiichi Sankyo - has posted its third straight quarter of losses, for the quarter ended March 31, 2009.
Citing foreign exchange instability, a 14 percent drop in its US market, and pricing strain in key markets, Ranbaxy posted a net loss of Rs 761 crore during the quarter – a dramatic turnaround from the Rs 153 crore net profit figures in 2008. In the previous two quarters, Ranbaxy posted losses of Rs 680 crore and Rs 394 crore.
Despite a difficult economic year, HCC, the engineering construction and infrastructure development company, has reported net profit of Rs 51.4 crore for the quarter ended March, 31,2009 compared with Rs 26.41 crore in the corresponding previous quarter.
The company has registered a growth of 94.47 per cent in its fourth quarter's net profit.
However, company's net sales during the quarter dipped to Rs 1,049.86 crore from Rs 1,071.73 crore last year, down by 2.04 per cent.
India's second-largest lender ICICI Bank today announced 35% drop in net profit at Rs 743.76 crore for the quarter ended March 31, 2009 when compared to Rs 1149.84 crore in the year-ago period. 
Leading drug maker Cipla on Friday reported 40.94% surge in its net profit for the fourth quarter ended March 31.
Navratna defence PSU Bharat Electronics Ltd. (BEL) on Friday informed that its net profit for the January-March 2009 quarter grew by 10.6% to Rs 559.43 crore over the corresponding year-ago period. 
Despite an economic slowdown, G
Exhibiting one of its worst quarterly performances ever, Ranbaxy Laboratories – now owned by Japanese firm Daiichi Sankyo - has posted its third straight quarter of losses, for the quarter ended March 31, 2009. 
Despite a difficult economic year, HCC, the engineering construction and infrastructure development company, has reported net profit of Rs 51.4 crore for the quarter ended March, 31,2009 compared with Rs 26.41 crore in the corresponding previous quarter. 
